Privia Health Group/$PRVA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Privia Health Group

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Ticker

$PRVA
Sector
Primary listing

Employees

1,140

PRVA Metrics

BasicAdvanced
$2.9B
218.50
$0.11
0.81
-

What the Analysts think about PRVA

Analyst ratings (Buy, Hold, Sell) for Privia Health Group stock.

Bulls say / Bears say

Privia Health reported strong first quarter 2025 revenue growth of 15.6% to $480.1 million and non-GAAP adjusted EPS of $0.22, beating consensus estimates and prompting a raise in full-year 2025 guidance to the mid-to-high end of ranges (Investing.com).
Total revenue in Q2 2025 rose 23.4% year-over-year to $521.2 million while practice collections grew 18.5%, underscoring accelerating network scale and strong demand for its physician enablement platform (GuruFocus).
Its Accountable Care Organizations delivered $233.1 million in shared savings through the Medicare Shared Savings Program for the 2024 performance year—a 32% increase over 2023—supporting management’s preliminary increase of full-year 2025 Adjusted EBITDA guidance to $113-$116 million (GlobeNewswire)
Despite robust top-line growth, Q2 2025 operating income fell 34.6% to $3.3 million and net income declined 22.5% to $2.7 million, highlighting margin pressure from new market investments and elevated operating costs (GlobeNewswire).
Privia Health’s Q2 2025 EPS of $0.02 missed the consensus estimate of $0.05, illustrating challenges in translating revenue growth into bottom-line earnings amid rising expenses (GuruFocus).
Although financial performance has improved, the stock is not yet in a buy zone as it awaits formation and breakout of a new chart pattern, suggesting limited near-term upside for technical traders (Investor’s Business Daily)
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.

PRVA Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

PRVA Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PRVA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs
Buy Privia Health Group stock | $PRVA Share Price | Lightyear